Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biomind Labs Inc

BMNDF
Current price
0.37 USD 0 USD (0.00%)
Last closed 0.47 CAD
ISIN CA0907021012
Sector Healthcare
Industry Biotechnology
Exchange NEO
Capitalization 45 129 072 CAD
Yield for 12 month +76.67 %
1Y
3Y
5Y
10Y
15Y
BMNDF
21.11.2021 - 28.11.2021

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. It is also developing new and preclinical drug candidates, including BMND02 for treating fibromyalgia, BMND03 for treating addictive disorders, BMND05 for treating chronic pain, BMND06 for treating inflammatory disorders, and BMND07 for treating major depressive disorder. The company is headquartered in Canelones, Uruguay. Address: Building Ceibo Of. 002, Canelones, Uruguay

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures BMNDF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -1 453 400 CAD
Operating Margin TTM
PE Ratio
Return On Assets TTM -173.81 %
PEG Ratio
Return On Equity TTM -498.21 %
Wall Street Target Price
Revenue TTM
Book Value -0.025 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.02 CAD
Diluted Eps TTM -0.02 CAD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BMNDF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BMNDF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:32.5
Payout Ratio
Last Split Date 28.07.2021
Dividend Date

Stock Valuation BMNDF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -10.2567
Price Book MRQ 117.5898

Financials BMNDF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BMNDF

For 52 weeks

0.025 CAD 1.1 CAD
50 Day MA 0.55 CAD
Shares Short Prior Month
200 Day MA 0.34 CAD
Short Ratio
Shares Short
Short Percent

Dynamics of changes in the value of assets

G

GDHG

0.10 USD Golden Heaven Group Holdings Ltd. Ordinary Shares -0.01 (-10.26%)
Detailed analytics
B

BIOVIC-B

2.60 SEK Biovica International AB (publ) -0.01 (-2.44%)
Detailed analytics
T

TECFF

0.10 USD TECO 2030 ASA 0 (0%)
Detailed analytics
M

MAB

284.00 GBX Mitchells & Butlers PLC +0.05 (+1.43%)
Detailed analytics
P

PSAT

5.05 EUR Passat Société Anonyme 0 (0%)
Detailed analytics